0 NASDAQ Companies - March 11, 2019Neon Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business UpdateRead More
0 NASDAQ Companies - March 11, 2019Tonix Pharmaceuticals Enrolls First Participant in the “RECOVERY” Study — a New Phase 3 Trial of Tonmya® for the Treatment of Posttraumatic Stress DisorderRead More
0 NASDAQ Companies - March 11, 2019Liquidia’s LIQ861 Meets Primary Endpoint in Pivotal Phase 3 INSPIRE Study in Patients with Pulmonary Arterial HypertensionRead More
0 NASDAQ Companies - March 11, 2019Lexicon Pharmaceuticals to Present at Upcoming Investor Conference Read More
0 NASDAQ Companies - March 11, 2019Athenex, Inc. Announces Fourth Quarter and Year Ended December 31, 2018 Financial Results and Provides Corporate UpdateRead More
0 NASDAQ Companies - March 11, 2019Stemline In-Licenses Worldwide Rights to Novel Selective RET Inhibitor (SL-1001); Expands Oncology PipelineRead More
0 NASDAQ Companies - March 11, 2019Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute PainRead More
0 NASDAQ Companies - March 11, 2019Yuhan Corp and Sorrento Therapeutics Announce Completion of Phase 1 Clinical Study of Anti-PD-L1 Antibody IMC-001Read More
0 NASDAQ Companies - March 11, 2019Rosehill Resources announces David L. French as Chief Executive OfficerRead More
